PKM2 Regulates HSP90-Mediated Stability of the IGF-1R Precursor Protein and Promotes Cancer Cell Survival during Hypoxia
Open Access
Abstract
Insulin-like growth factor-1 receptor (IGF-1R), an important factor in promoting cancer cell growth and survival, is commonly upregulated in cancer cells. However, amplification of the IGF1R gene is extremely rare in tumors. Here, we have provided insights into the mechanisms underlying the regulation of IGF-1R protein expression. We found that PKM2 serves as a non-metabolic protein that binds to and increases IGF-1R protein expression by promoting the interaction between IGF-1R and heat-shock protein 90 (HSP90). PKM2 depletion decreases HSP90 binding to IGF-1R precursor, thereby reducing IGF-1R precursor stability and the basal level of mature IGF-1R. Consequently, PKM2 knockdown inhibits the activation of AKT, the key downstream effector of IGF-1R signaling, and increases apoptotic cancer cell death during hypoxia. Notably, we clinically verified the PKM2-regulated expression of IGF-1R through immunohistochemical staining in a tissue microarray of 112 lung cancer patients, demonstrating a significant positive correlation (r = 0.5208, p < 0.0001) between PKM2 and IGF-1R expression. Together, the results of a previous report demonstrated that AKT mediates PKM2 phosphorylation at serine-202; these results suggest that IGF-1R signaling and PKM2 mutually regulate each other to facilitate cell growth and survival, particularly under hypoxic conditions, in solid tumors with dysregulated IGF-1R expression.Keywords
This publication has 48 references indexed in Scilit:
- Insulin-like growth factor receptor signaling in tumorigenesis and drug resistance: a challenge for cancer therapyJournal of Hematology & Oncology, 2020
- Pyruvate Kinase M2 and Cancer: The Role of PKM2 in Promoting TumorigenesisFrontiers in Oncology, 2020
- 40 YEARS OF IGF1: IGF1 receptor signaling pathwaysJournal of Molecular Endocrinology, 2018
- PKM2, cancer metabolism, and the road aheadEMBO Reports, 2016
- Molecular Pathways: Clinical Applications and Future Direction of Insulin-like Growth Factor-1 Receptor Pathway BlockadeClinical Cancer Research, 2015
- Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapyWorld Journal of Gastroenterology, 2014
- Notch-1 stimulates survival of lung adenocarcinoma cells during hypoxia by activating the IGF-1R pathwayOncogene, 2010
- Regulation of apoptosis by insulin-like growth factor (IGF)-ICytokine & Growth Factor Reviews, 2006
- Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.2002
- Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion.2000